Cargando…
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941533/ https://www.ncbi.nlm.nih.gov/pubmed/27403717 http://dx.doi.org/10.1038/srep29425 |
_version_ | 1782442312585969664 |
---|---|
author | Kurg, Reet Reinsalu, Olavi Jagur, Sergei Õunap, Kadri Võsa, Liisi Kasvandik, Sergo Padari, Kärt Gildemann, Kiira Ustav, Mart |
author_facet | Kurg, Reet Reinsalu, Olavi Jagur, Sergei Õunap, Kadri Võsa, Liisi Kasvandik, Sergo Padari, Kärt Gildemann, Kiira Ustav, Mart |
author_sort | Kurg, Reet |
collection | PubMed |
description | Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like particles (VLPs) when expressed in the mammalian cells. In this study, five different melanoma antigens, MAGEA4, MAGEA10, MART1, TRP1 and MCAM, were incorporated into the VLPs and their localization within the particles was determined. Our data show that the MAGEA4 and MAGEA10 proteins as well as MCAM are expressed on the surface of VLPs. The compartmentalization of exogenously expressed cancer antigens within the VLPs did not depend on the localization of the protein within the cell. Comparison of the protein content of VLPs by LC-MS/MS-based label-free quantitative proteomics showed that VLPs carrying different cancer antigens are very similar to each other, but differ to some extent from VLPs without recombinant antigen. We suggest that retrovirus Gag based virus-like particles carrying recombinant antigens have a potential to be used in cancer immunotherapy. |
format | Online Article Text |
id | pubmed-4941533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49415332016-07-20 Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens Kurg, Reet Reinsalu, Olavi Jagur, Sergei Õunap, Kadri Võsa, Liisi Kasvandik, Sergo Padari, Kärt Gildemann, Kiira Ustav, Mart Sci Rep Article Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like particles (VLPs) when expressed in the mammalian cells. In this study, five different melanoma antigens, MAGEA4, MAGEA10, MART1, TRP1 and MCAM, were incorporated into the VLPs and their localization within the particles was determined. Our data show that the MAGEA4 and MAGEA10 proteins as well as MCAM are expressed on the surface of VLPs. The compartmentalization of exogenously expressed cancer antigens within the VLPs did not depend on the localization of the protein within the cell. Comparison of the protein content of VLPs by LC-MS/MS-based label-free quantitative proteomics showed that VLPs carrying different cancer antigens are very similar to each other, but differ to some extent from VLPs without recombinant antigen. We suggest that retrovirus Gag based virus-like particles carrying recombinant antigens have a potential to be used in cancer immunotherapy. Nature Publishing Group 2016-07-11 /pmc/articles/PMC4941533/ /pubmed/27403717 http://dx.doi.org/10.1038/srep29425 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Kurg, Reet Reinsalu, Olavi Jagur, Sergei Õunap, Kadri Võsa, Liisi Kasvandik, Sergo Padari, Kärt Gildemann, Kiira Ustav, Mart Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title | Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title_full | Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title_fullStr | Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title_full_unstemmed | Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title_short | Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens |
title_sort | biochemical and proteomic characterization of retrovirus gag based microparticles carrying melanoma antigens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941533/ https://www.ncbi.nlm.nih.gov/pubmed/27403717 http://dx.doi.org/10.1038/srep29425 |
work_keys_str_mv | AT kurgreet biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT reinsaluolavi biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT jagursergei biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT ounapkadri biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT vosaliisi biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT kasvandiksergo biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT padarikart biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT gildemannkiira biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens AT ustavmart biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens |